Filters
reset all| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
F2 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 4 | 1 |
|
F5 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 5 | 1 |
|
F2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
F5 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Invitae Pharmacogenomics Panel Invitae United States | 43 | 37 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 342 | 156 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Stroke, ischemic, susceptibility to, 601367, Multifactorial (MLPA) Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Intergen Genetic Diagnosis and Research Centre Turkey | 1 | 1 |
|
Aventus Biolabs United States | 5 | 1 |
|
Aventus Biolabs United States | 4 | 1 |
|
Aventus Biolabs United States | 36 | 21 |
|
Aventus Biolabs United States | 61 | 30 |
|
Aventus Biolabs United States | 19 | 11 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 525 | 339 |
|
Invitae Hereditary Thrombophilia Panel Invitae United States | 24 | 11 |
|
IGENOMIX Spain | 4 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.